CCR2 and neoplasm: MMTV-PyMT mice with a genetic deletion of either CCL2 or CCR2 exhibited earlier onset of tumor growth and increased metastasis, though the rate of primary tumor growth was enhanced, implying an anti-tumor role for CCL2 in early stages of tumor progression and in metastasis [16].